
Loading, please wait...

Loading, please wait...

Vaccine-preventable diseases remain a significant global health threat. Pediatric COVID-19 vaccine hesitancy has emerged as a major hurdle in achieving widespread community protection. Recent systematic reviews indicate that approximately one in five parents remains skeptical about vaccinating their children against COVID-19. This reluctance often stems from a complex interplay of safety concerns, risk perception, and medical literacy.
Consequently, clinicians must understand the underlying reasons for this hesitation. In India, while parental acceptance rates are generally high, specific barriers continue to persist. For instance, many parents believe that natural immunity from previous infections is sufficient for their children. Therefore, proactive communication is essential to bridge the knowledge gap and foster trust.
Research across multiple countries highlights safety and trust as the most common concerns. Specifically, every study in a recent systematic review identified safety as a primary driver of parental refusal. Additionally, lack of knowledge and inaccurate risk perception contribute significantly to the problem. Moreover, cultural manifestations and accessibility barriers often fluctuate depending on the specific region and population demographic.
Clinicians can effectively mitigate these concerns through tailored education programs. Furthermore, simplifying the distribution process helps reduce accessibility barriers for busy families. Notably, local community leaders and healthcare providers remain the most trusted sources of information for parents. Thus, clear and empathetic risk communication from public health institutions is vital for making sound immunization policies.
Health literacy plays a critical role in vaccine acceptance. Doctors should prioritize active listening to understand specific parental fears. For example, addressing concerns about long-term side effects with evidence-based data can reassure hesitant caregivers. Additionally, bundling COVID-19 vaccinations with routine pediatric immunizations may improve uptake by normalizing the procedure.
Finally, social media fact-checking and community outreach remain powerful tools. By engaging with parents through trusted channels, healthcare providers can dismantle misconceptions. Ultimately, a multi-faceted approach involving education, accessibility, and transparent communication will simplify future immunization planning.
The most common reasons include concerns about vaccine safety, lack of trust in health institutions, and the belief that children are less vulnerable to severe COVID-19 outcomes.
Doctors should provide clear, evidence-based recommendations and address specific parental concerns using active listening and empathetic communication.
While natural infection provides some protection, vaccination offers a more consistent and robust immune response, reducing the risk of reinfection and severe complications like MIS-C.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Amanat N et al. COVID-19 vaccination hesitancy in pediatrics: a systematic review. Syst Rev. 2026 Apr 18. doi: 10.1186/s13643-026-03110-3. PMID: 41998754.
Mehta K, et al. Healthcare provider perspectives regarding COVID-19 vaccination for children in India. BMJ Paediatrics Open. 2023;7(1):e002165. doi: 10.1136/bmjpo-2023-002165.
Gaur RK, et al. Unveiling parental perspectives: COVID-19 vaccination for children in India. J Family Med Prim Care. 2024 Apr;13(4):1485-1492. doi: 10.4103/jfmpc.jfmpc_1485_23.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Explore the drivers of pediatric COVID-19 vaccine hesitancy and discover evidence-based strategies to improve parental trust and clinical communication....
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today